1. Albiglutide for the treatment of type 2 diabetes mellitus: An integrated safety analysis of the HARMONY phase 3 trials. (April 2017) Authors: Ahrén, Bo; Carr, Molly C.; Murphy, Karen; Perkins, Christopher; Rendell, Marc; Mallory, Jason; Wilson, Timothy; Johnson, Susan Journal: Diabetes research and clinical practice Issue: Volume 126(2017) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Issue 10184 (11th May 2019) Authors: Heerspink, Hiddo J L; Parving, Hans-Henrik; Andress, Dennis L; Bakris, George; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kitzman, Dalane W; Kohan, Donald; Makino, Hirofumi; McMurray, John J V; Melnick, Joel Z; Miller, Michael G; Pergola, Pablo E; Perkovic, Vlado; Tobe, Sheldon; Yi, Tingting; Wigderso... Journal: Lancet Issue: Volume 393:Issue 10184(2019) Page Start: 1937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Glargine safety, diabetes and cancer. (March 2013) Authors: Rendell, Marc; Akturk, Halis Kaan; Tella, Sri Harsha Journal: Expert opinion on drug safety Issue: Volume 12:Number 2(2013:Mar.) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Improved Quality of Life in Unselected Insulin Pump-Treated Children with Type 1 Diabetes in Eastern Nebraska. (March 2013) Authors: Rendell, Sara; Kosoko-Lasaki, Omofosolade; Penny, Greg; Cook, Cynthia T.; Sharma, Apoorva; Austin, William P.; Rendell, Marc Journal: Journal of diabetes science and technology Issue: Volume 7:Number 2(2013) Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Linagliptin for the treatment of Type 2 diabetes. (January 2014) Authors: Tella, Sri Harsha; Akturk, Halis Kaan; Rendell, Marc Journal: Diabetes management Issue: Volume 4:Number 1(2014) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Linagliptin for the treatment of Type 2 diabetes. (January 2014) Authors: Tella, Sri Harsha; Akturk, Halis Kaan; Rendell, Marc Journal: Diabetes management Issue: Volume 4:Number 1(2014) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-Term Performance of Point-of-Care Hemoglobin A1c Assays. (November 2016) Authors: Paknikar, Sujaytha; Sarmah, Rohan; Sivaganeshan, Losika; Welke, Adam; Rizzo, Al; Larson, Kirk; Rendell, Marc Journal: Journal of diabetes science and technology Issue: Volume 10:Number 6(2016:Nov.) Page Start: 1308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacotherapeutic options for prediabetes. (2nd January 2021) Authors: Rendell, Marc Journal: Expert opinion on pharmacotherapy Issue: Volume 22:Number 1(2021) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Premix insulins in type 1 diabetes: the coming of degludec/aspart. (3rd April 2019) Authors: Rendell, Marc Journal: Expert opinion on drug metabolism and toxicology Issue: Volume 15:Number 4(2019) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Screening for familial and hereditary prostate cancer. Issue 11 (5th February 2016) Authors: Lynch, Henry T.; Kosoko‐Lasaki, Omofolasade; Leslie, Stephen W.; Rendell, Marc; Shaw, Trudy; Snyder, Carrie; D'Amico, Anthony V.; Buxbaum, Sarah; Isaacs, William B.; Loeb, Stacy; Moul, Judd W.; Powell, Isaac Journal: International journal of cancer Issue: Volume 138:Issue 11(2016:Jun. 01) Page Start: 2579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗